DGS Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$913K Buy
2,595
+506
+24% +$180K 0.15% 129
2025
Q4
$684K Buy
2,089
+305
+17% +$96.7K 0.12% 160
2025
Q3
$503K Buy
1,784
+486
+37% +$141K 0.09% 189
2025
Q2
$363K Sell
1,298
-13
-1% -$3.68K 0.07% 208
2025
Q1
$409K Sell
1,311
-191
-13% -$56.4K 0.11% 182
2024
Q4
$392K Sell
1,502
-997
-40% -$296K 0.1% 182
2024
Q3
$805K Sell
2,499
-104
-4% -$34K 0.22% 95
2024
Q2
$813K Sell
2,603
-312
-11% -$91.7K 0.23% 87
2024
Q1
$829K Sell
2,915
-376
-11% -$110K 0.24% 77
2023
Q4
$948K Buy
3,291
+55
+2% +$15K 0.36% 48
2023
Q3
$870K Buy
3,236
+261
+9% +$65.1K 0.43% 48
2023
Q2
$661K Buy
2,975
+38
+1% +$8.82K 0.33% 67
2023
Q1
$710K Sell
2,937
-143
-5% -$35.1K 0.4% 50
2022
Q4
$809K Buy
3,080
+508
+20% +$136K 0.53% 41
2022
Q3
$580K Buy
2,572
+262
+11% +$63.5K 0.39% 46
2022
Q2
$562K Buy
2,310
+272
+13% +$66.7K 0.45% 43
2022
Q1
$493K Buy
2,038
+271
+15% +$62.3K 0.3% 57
2021
Q4
$398K Buy
+1,767
New +$373K 0.25% 68

Other funds holding AMGN

DGS Capital Management's AMGN Position: Q1 2026 in Review

DGS Capital Management increased its Amgen (AMGN) stake by 24% in Q1 2026, buying an estimated $180K and bringing the position to 2,595 shares worth $913K. The position accounts for 0.15% of the portfolio, ranked #129.

DGS Capital Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $948K in Q4 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • DGS Capital Management held 2,595 shares of Amgen worth $913K as of Q1 2026.
  • DGS Capital Management bought 506 Amgen shares in Q1 2026, an estimated $180K.
  • Amgen made up 0.15% of DGS Capital Management's portfolio in Q1 2026, its #129 holding.
  • DGS Capital Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Amgen position peaked at $948K in Q4 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.